Coordinated regulation of myeloid cells by tumours (original) (raw)

• Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunol. 11, 889–896 (2010).
  Article CAS Google Scholar
• Coussens, L. M. & Pollard, J. W. Leukocytes in mammary development and cancer. Cold Spring Harb. Perspect. Biol. 3, a003285 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Khazaie, K. et al. The significant role of mast cells in cancer. Cancer Metastasis Rev. 30, 45–60 (2011).
  Article CAS PubMed Google Scholar
• Liu, K. & Nussenzweig, M. C. Origin and development of dendritic cells. Immunol. Rev. 234, 45–54 (2010).
  Article CAS PubMed Google Scholar
• Fogg, D. K. et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83–87 (2006).
  Article CAS PubMed Google Scholar
• Onai, N. et al. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nature Immunol. 8, 1207–1216 (2007).
  Article CAS Google Scholar
• Naik, S. H. et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nature Immunol. 8, 1217–1226 (2007).
  Article CAS Google Scholar
• Shortman, K. & Heath, W. R. The CD8+ dendritic cell subset. Immunol. Rev. 234, 18–31 (2010).
  Article CAS PubMed Google Scholar
• Idoyaga, J. & Steinman, R. M. SnapShot: dendritic cells. Cell 146, 660–660.e2 (2011).
  Article CAS PubMed Google Scholar
• Swiecki, M. & Colonna, M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol. Rev. 234, 142–162 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dominguez, P. M. & Ardavin, C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234, 90–104 (2010).
  Article CAS PubMed Google Scholar
• Gabrilovich, D. I. The mechanisms and functional significance of tumour-induced dendritic-cell defects. Nature Rev. Immunol. 4, 941–952 (2004).
  Article CAS Google Scholar
• Pinzon-Charry, A. et al. Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer. Br. J. Cancer 97, 1251–1259 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Perrot, I. et al. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J. Immunol. 178, 2763–2769 (2007).
  Article CAS PubMed Google Scholar
• Bellone, G. et al. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J. Immunol. 177, 3448–3460 (2006).
  Article CAS PubMed Google Scholar
• Lee, B. N. et al. Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions. Cancer 107, 999–1007 (2006).
  Article CAS PubMed Google Scholar
• Ormandy, L. A. et al. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J. Gastroenterol. 12, 3275–3282 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Pinzon-Charry, A., Maxwell, T. & Lopez, J. A. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol. Cell Biol. 83, 451–461 (2005).
  Article CAS PubMed Google Scholar
• Mancino, A. et al. Divergent effects of hypoxia on dendritic cell functions. Blood 112, 3723–3734 (2008).
  Article CAS PubMed Google Scholar
• Elia, A. R. et al. Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J. Leukoc. Biol. 84, 1472–1482 (2008).
  Article CAS PubMed Google Scholar
• Yang, M. et al. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol. Cell Biol. 88, 165–171 (2010).
  Article CAS PubMed Google Scholar
• Novitskiy, S. V. et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112, 1822–1831 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gottfried, E. et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107, 2013–2021 (2006).
  Article CAS PubMed Google Scholar
• Herber, D. L. et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nature Med. 16, 880–886 (2010).
  Article CAS PubMed Google Scholar
• Ghiringhelli, F. et al. Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 202, 919–929 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, A., Schildknecht, A., Nguyen, L. T. & Ohashi, P. S. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol. Lett. 127, 77–84 (2010).
  Article CAS PubMed Google Scholar
• Norian, L. A. et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res. 69, 3086–3094 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Watkins, S. K. et al. FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J. Clin. Invest. 121, 1361–1372 (2011).
  Article PubMed PubMed Central Google Scholar
• Dumitriu, I. E., Dunbar, D. R., Howie, S. E., Sethi, T. & Gregory, C. D. Human dendritic cells produce TGF-β1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 182, 2795–2807 (2009).
  Article CAS PubMed Google Scholar
• Liu, Q. et al. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J. Immunol. 182, 6207–6216 (2009).
  Article CAS PubMed Google Scholar
• Lee, J. R. et al. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab. Invest. 83, 1457–1466 (2003).
  Article CAS PubMed Google Scholar
• Munn, D. H. et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114, 280–290 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Baban, B. et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183, 2475–2483 (2009).
  Article CAS PubMed Google Scholar
• Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature Rev. Immunol. 8, 958–969 (2008).
  Article CAS Google Scholar
• Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555 (2002).
  Article CAS PubMed Google Scholar
• Mantovani, A., Sica, A., Allavena, P., Garlanda, C. & Locati, M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 70, 325–330 (2009).
  Article CAS PubMed Google Scholar
• Mantovani, A. & Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231–237 (2010).
  Article CAS PubMed Google Scholar
• Steidl, C. et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 362, 875–885 (2010). This study identified a gene signature of TAMs that was associated with primary treatment failure in patients with Hodgkin's lymphoma, and demonstrated that the number of macrophages in patients with Hodgkin's lymphoma is prognostic of clinical outcome.
  Article CAS PubMed PubMed Central Google Scholar
• Lin, E. Y. et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238–11246 (2006).
  Article CAS PubMed Google Scholar
• Qian, B. et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE 4, e6562 (2009). This study demonstrated that macrophages have a crucial role in metastatic cell seeding and in the progression of metastatic disease.
  Article CAS PubMed PubMed Central Google Scholar
• Zheng, Y. et al. Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis. Blood 114, 3625–3628 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gordon, S. & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593–604 (2010).
  Article CAS PubMed Google Scholar
• DeNardo, D. G. et al. CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91–102 (2009). This study demonstrated that, in transgenic mice with mammary carcinomas, TAMs develop a pro-tumour and pro-metastatic phenotype in response to CD4+ T cell-derived IL-4. These findings demonstrate that the adaptive immune system plays a substantial part in driving the pro-tumour activity of the innate immune system.
  Article CAS PubMed PubMed Central Google Scholar
• Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature Immunol. 10, 1178–1184 (2009).
  Article CAS Google Scholar
• Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942–949 (2004).
  Article CAS PubMed Google Scholar
• Torroella-Kouri, M. et al. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 69, 4800–4809 (2009).
  Article CAS PubMed Google Scholar
• Kuang, D. M. et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206, 1327–1337 (2009). This study demonstrated that CD68+ monocytes in the peritumoural stroma of patients with hepatocellular carcinoma express PDL1, induce T cell anergy, promote tumour progression and are associated with poor survival.
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez, P. C. et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64, 5839–5849 (2004).
  Article CAS PubMed Google Scholar
• Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222–225 (2011). Using a transgenic mouse mammary carcinoma system, this study demonstrated that tumour cells and stromal cells produce CCL2, which recruits inflammatory monocytes and macrophages that promote metastasis. Blocking CCL2–CCR2 signalling inhibits the recruitment of inflammatory monocytes, inhibits metastasis and increases survival rates.
  Article CAS PubMed PubMed Central Google Scholar
• O'Connell, P. A., Surette, A. P., Liwski, R. S., Svenningsson, P. & Waisman, D. M. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 116, 1136–1146 (2010).
  Article CAS PubMed Google Scholar
• Phipps, K., Surette, A., O'Connell, P. & Weaisman, D. Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites. Cancer Res. 71, 6676–6683 (2011).
  Article CAS PubMed Google Scholar
• Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6Chigh monocytes. Cancer Res. 70, 5728–5739 (2010). This study demonstrated that distinct subpopulations of TAMs can be identified based on their expression of M1- and M2-like markers and that these different subpopulations localize to different regions of solid tumours, where they have distinct functions.
  Article CAS PubMed Google Scholar
• Pucci, F. et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114, 901–914 (2009).
  Article CAS PubMed Google Scholar
• Ojalvo, L. S., Whittaker, C. A., Condeelis, J. S. & Pollard, J. W. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J. Immunol. 184, 702–712 (2010).
  Article CAS PubMed Google Scholar
• Tiemessen, M. M. et al. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl Acad. Sci. USA 104, 19446–19451 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Song, L. et al. Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J. Clin. Invest. 119, 1524–1536 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411–423 (2005).
  Article CAS PubMed Google Scholar
• Wong, S. C. et al. Macrophage polarization to a unique phenotype driven by B cells. Eur. J. Immunol. 40, 2296–2307 (2010).
  Article CAS PubMed Google Scholar
• Andreu, P. et al. FcRγ activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17, 121–134 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hagemann, T. et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 176, 5023–5032 (2006).
  Article CAS PubMed Google Scholar
• Summers, C. et al. Neutrophil kinetics in health and disease. Trends Immunol. 31, 318–324 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Donskov, F. & von der Maase, H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J. Clin. Oncol. 24, 1997–2005 (2006).
  Article PubMed Google Scholar
• Jensen, H. K. et al. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709–4717 (2009).
  Article PubMed Google Scholar
• Ilie, M. et al. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil- to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 118, 1726–1737 (2012).
  Article CAS PubMed Google Scholar
• Li, Y. W. et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 54, 497–505 (2011).
  Article CAS PubMed Google Scholar
• Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447–458 (2004).
  Article CAS PubMed Google Scholar
• Shojaei, F. et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450, 825–831 (2007).
  Article CAS PubMed Google Scholar
• Kowanetz, M. et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl Acad. Sci. USA 107, 21248–21255 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Nozawa, H., Chiu, C. & Hanahan, D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. USA 103, 12493–12498 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Houghton, A. M. et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nature Med. 16, 219–223 (2010).
  Article CAS PubMed Google Scholar
• Granot, Z. et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20, 300–314 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell 16, 183–194 (2009). In this study, neutrophils are shown to undergo a TGFβ-regulated shift between different transitional activation stages.
  Article CAS PubMed PubMed Central Google Scholar
• De Santo, C. et al. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nature Immunol. 11, 1039–1046 (2010).
  Article CAS Google Scholar
• Davey, M. S. et al. Failure to detect production of IL-10 by activated human neutrophils. Nature Immunol. 12, 1017–1018 (2011).
  Article CAS Google Scholar
• Gabrilovich, D. I. et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67, 425–426 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Peranzoni, E. et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22, 238–244 (2010).
  Article CAS PubMed Google Scholar
• Greten, T. F., Manns, M. P. & Korangy, F. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11, 802–807 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dolcetti, L. et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40, 22–35 (2010).
  Article CAS PubMed Google Scholar
• Youn, J. I., Nagaraj, S., Collazo, M. & Gabrilovich, D. I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791–5802 (2008).
  Article CAS PubMed Google Scholar
• Movahedi, K. et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233–4244 (2008).
  Article CAS PubMed Google Scholar
• Mandruzzato, S. et al. IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients. J. Immunol. 182, 6562–6568 (2009).
  Article CAS PubMed Google Scholar
• Haile, L. A., Gamrekelashvili, J., Manns, M. P., Korangy, F. & Greten, T. F. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. J. Immunol. 185, 203–210 (2010).
  Article CAS PubMed Google Scholar
• Van Ginderachter, J. A. et al. Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 108, 525–535 (2006).
  Article CAS PubMed Google Scholar
• Bronte, V. et al. Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells. Blood 96, 3838–3846 (2000).
  CAS PubMed Google Scholar
• Sica, A. & Bronte, V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155–1166 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kusmartsev, S. et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 14, 8270–8278 (2008).
  Article CAS PubMed Google Scholar
• Diaz-Montero, C. M. et al. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58, 49–59 (2009).
  Article CAS PubMed Google Scholar
• Solito, S. et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 118, 2254–2265 (2011). A relationship between human MDSCs and immature promyelocytes is identified in this study. More importantly, the levels of these cells in the blood are shown to be inversely correlated with the response to chemotherapy in patients with breast or colon cancer.
  Article CAS PubMed PubMed Central Google Scholar
• Corzo, C. A. et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182, 5693–5701 (2009).
  Article CAS PubMed Google Scholar
• Raychaudhuri, B. et al. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro-Oncology 13, 591–599 (2011).
  Article PubMed PubMed Central Google Scholar
• Rodriguez, P. C. et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69, 1553–1560 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Vuk-Pavlovic, S. et al. Immunosuppressive CD14+HLA-DRlow/− monocytes in prostate cancer. Prostate 70, 443–455 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hoechst, B. et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells. Gastroenterology 135, 234–243 (2008).
  Article CAS PubMed Google Scholar
• Filipazzi, P. et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte–macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546–2553 (2007).
  Article CAS PubMed Google Scholar
• Serafini, P. et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J. Exp. Med. 203, 2691–2702 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Youn, J.-I., Collazo, M., Shalova, I., Biswas, S. & Gabrilovich, D. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91, 167–181 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Brandau, S. et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol. 89, 311–317 (2011).
  Article CAS PubMed Google Scholar
• Lu, T. et al. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J. Clin. Invest. 121, 4015–4029 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bronte, V. & Zanovello, P. Regulation of immune responses by L-arginine metabolism. Nature Rev. Immunol. 5, 641–654 (2005).
  Article CAS Google Scholar
• Nagaraj, S. et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nature Med. 13, 828–835 (2007).
  Article CAS PubMed Google Scholar
• Molon, B. et al. Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J. Exp. Med. 208, 1949–1962 (2011). References 99, 101 and 102 illustrate the complex negative influence on T cells of peroxynitrite, which is produced in the tumour environment or in tumour-draining lymph nodes by either myeloid or tumour cells.
  Article CAS PubMed PubMed Central Google Scholar
• Raes, G. et al. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174, 6561 (2005).
  Article CAS PubMed Google Scholar
• Lechner, M. G., Liebertz, D. J. & Epstein, A. L. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185, 2273–2284 (2010).
  Article CAS PubMed Google Scholar
• Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev. Immunol. 9, 162–174 (2009).
  Article CAS Google Scholar
• Li, Q., Pan, P. Y., Gu, P., Xu, D. & Chen, S. H. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity. Cancer Res. 64, 1130–1139 (2004).
  Article CAS PubMed Google Scholar
• Narita, Y., Wakita, D., Ohkur, T., Chamoto, K. & Nishimura, T. Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells. Biomed. Res. 30, 7–15 (2009).
  Article CAS PubMed Google Scholar
• Kusmartsev, S. & Gabrilovich, D. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174, 4880–4891 (2005).
  Article CAS PubMed Google Scholar
• Corzo, C. A. et al. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207, 2439–2453 (2010). This study demonstrated that MDSCs in the tumour microenvironment rapidly differentiate into TAMs and that this effect is mediated by hypoxia.
  Article CAS PubMed PubMed Central Google Scholar
• Doedens, A. L. et al. Macrophage expression of hypoxia-inducible factor-1α suppresses T-cell function and promotes tumor progression. Cancer Res. 70, 7465–7475 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P. & Ostrand-Rosenberg, S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70, 68–77 (2010).
  Article CAS PubMed Google Scholar
• Schmielau, J. & Finn, O. J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756–4760 (2001).
  CAS PubMed Google Scholar
• Mazzoni, A. et al. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168, 689–695 (2002).
  Article CAS PubMed Google Scholar
• Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D. & Ostrand-Rosenberg, S. Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J. Immunol. 183, 937–944 (2009).
  Article CAS PubMed Google Scholar
• Sakuishi, K., Jayaraman, P., Behar, S. M., Anderson, A. C. & Kuchroo, V. K. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol. 32, 345–349 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Li, H., Han, Y., Guo, Q., Zhang, M. & Cao, X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1. J. Immunol. 182, 240–249 (2009).
  Article CAS PubMed Google Scholar
• Hoechst, B. et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50, 799–807 (2009).
  Article CAS PubMed Google Scholar
• Elkabets, M. et al. IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur. J. Immunol. 40, 3347–3357 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Pan, P. Y. et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 70, 99–108 (2010).
  Article CAS PubMed Google Scholar
• Huang, B. et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123–1131 (2006).
  Article CAS PubMed Google Scholar
• Serafini, P., Mgebroff, S., Noonan, K. & Borrello, I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68, 5439–5449 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hoechst, B., Gamrekelashvili, J., Manns, M. P., Greten, T. F. & Korangy, F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 117, 6532–6541 (2011).
  Article CAS PubMed Google Scholar
• Watanabe, S. et al. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 181, 3291–3300 (2008).
  Article CAS PubMed Google Scholar
• Sinha, P. et al. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 117, 5381–5390 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gallina, G. et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116, 2777–2790 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Nagaraj, S. et al. Antigen-specific CD4+ T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 72, 928–938 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M. & Ostrand-Rosenberg, S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179, 977–983 (2007).
  Article CAS PubMed Google Scholar
• Ostrand-Rosenberg, S. & Sinha, P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499–4506 (2009).
  Article CAS PubMed Google Scholar
• Bunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P. & Ostrand-Rosenberg, S. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J. Leukoc. Biol. 85, 996–1004 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, C. E., Gan, J., Zhang, R. D., Cheng, Y. R. & Huang, G. J. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand. J. Gastroenterol. 46, 156–164 (2011).
  Article CAS PubMed Google Scholar
• Marigo, I. et al. Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor. Immunity 32, 790–802 (2010). This study shows that the transcription factor C/EBPβ, which is essential for emergency granulopoiesis during inflammatory conditions, regulates the immunosuppressive activity of myeloid cells that are conditioned by growing tumours and provides the basis for molecular targeting of common tolerogenic pathways in myeloid cells.
  Article CAS PubMed Google Scholar
• Sinha, P. et al. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181, 4666–4675 (2008).
  Article CAS PubMed Google Scholar
• Bunt, S. K., Sinha, P., Clements, V. K., Leips, J. & Ostrand-Rosenberg, S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176, 284–290 (2006).
  Article CAS PubMed Google Scholar
• Yang, L. et al. Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13, 23–35 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, B. et al. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett. 252, 86–92 (2007).
  Article CAS PubMed Google Scholar
• Greifenberg, V., Ribechini, E., Rossner, S. & Lutz, M. B. Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur. J. Immunol. 39, 2865–2876 (2009).
  Article CAS PubMed Google Scholar
• Sinha, P., Clements, V. K., Fulton, A. M. & Ostrand-Rosenberg, S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 67, 4507–4513 (2007).
  Article CAS PubMed Google Scholar
• Zhang, H. G. & Grizzle, W. E. Exosomes and cancer: a newly described pathway of immune suppression. Clin. Cancer Res. 17, 959–964 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, T. et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Med. 10, 48–54 (2004).
  Article CAS PubMed Google Scholar
• Cheng, F. et al. A critical role for Stat3 signaling in immune tolerance. Immunity 19, 425–436 (2003).
  Article CAS PubMed Google Scholar
• Nefedova, Y. et al. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J. Immunol. 172, 464–474 (2004).
  Article CAS PubMed Google Scholar
• Nefedova, Y. et al. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the Janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 65, 9525–9535 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V. & Kiessling, R. Immature immunosuppressive CD14+HLA-DR−/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-SIGN. Cancer Res. 70, 4335–4345 (2010).
  Article CAS PubMed Google Scholar
• Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Rev. Cancer 9, 798–809 (2009).
  Article CAS Google Scholar
• Foell, D., Wittkowski, H., Vogl, T. & Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28–37 (2007).
  Article CAS PubMed Google Scholar
• Cheng, P. et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205, 2235–2249 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Farren, M. R., Carlson, L. M. & Lee, K. P. Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase CβII expression. Immunol. Res. 46, 165–176 (2010).
  Article CAS PubMed Google Scholar
• Zhang, H. et al. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116, 2462–2471 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Sander, L. E. et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453–1464 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Sinha, P., Clements, V. & Ostrand-Rosenberg, S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174, 636–645 (2005).
  Article CAS PubMed Google Scholar
• Sinha, P., Clements, V. K. & Ostrand-Rosenberg, S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res. 65, 11743–11751 (2005).
  Article CAS PubMed Google Scholar
• Bronte, V. et al. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170, 270–278 (2003).
  Article CAS PubMed Google Scholar
• Terabe, M. et al. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198, 1741–1752 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Munera, V. et al. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 251, 120–126 (2010).
  Article PubMed Google Scholar
• Ishii, M. et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114, 3244–3254 (2009). This study demonstrates that M2 macrophage polarization is partially regulated epigenetically by chromatin or histone remodelling through an IL-4- and STAT6-dependent mechanism.
  Article CAS PubMed PubMed Central Google Scholar
• Satoh, T. et al. The Jmjd3–Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunol. 11, 936–944 (2010).
  Article CAS Google Scholar
• Martino, A. et al. Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J. Immunol. 184, 2038–2047 (2010).
  Article CAS PubMed Google Scholar
• Liu, Y. et al. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am. J. Pathol. 176, 2490–2499 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J. Immunol. 182, 3801–3808 (2009).
  Article CAS PubMed Google Scholar
• Donkor, M. K. et al. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int. Immunopharmacol. 9, 937–948 (2009).
  Article CAS PubMed Google Scholar
• Eruslanov, E., Daurkin, I., Ortiz, J., Vieweg, J. & Kusmartsev, S. Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells. J. Leukoc. Biol. 88, 839–848 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez, P. C. et al. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202, 931–939 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Clark, C. E. et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 67, 9518–9527 (2007).
  Article CAS PubMed Google Scholar
• Lesina, M. et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19, 456–469 (2011).
  Article CAS PubMed Google Scholar
• Fukuda, A. et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19, 441–455 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pufnock, J. S. & Rothstein, J. L. Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression. J. Immunol. 182, 5498–5506 (2009).
  Article CAS PubMed Google Scholar
• Borrello, M. G. et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl Acad. Sci. USA 102, 14825–14830 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Melani, C., Chiodoni, C., Forni, G. & Colombo, M. P. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102, 2138–2145 (2003).
  Article CAS PubMed Google Scholar
• Stairs, D. B. et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 19, 470–483 (2011). In the model of autochthonous cancer, soluble factors released by tumour cells recruited and promoted the proliferation of immature myeloid cells, which possess immunosuppressive properties and promote desmoplasia by activating fibroblasts.
  Article CAS PubMed PubMed Central Google Scholar
• Highfill, S. L. et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116, 5738–5747 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• De Santo, C. et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl Acad. Sci. USA 102, 4185–4190 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Nagaraj, S. et al. Anti-inflammatory triterpenoid blocks immune suppressive function of myeloid-derived suppressor cells and improves immune response in cancer. Clin. Cancer Res. 16, 1812–1823 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ko, J. S. et al. Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained. Cancer Res. 70, 3526–3536 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ko, J. S. et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15, 2148–2157 (2009).
  Article CAS PubMed Google Scholar
• Ozao-Choy, J. et al. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69, 2514–2522 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• van Cruijsen, H. et al. Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival. Clin. Cancer Res. 14, 5884–5892 (2008).
  Article CAS PubMed Google Scholar
• Xin, H. et al. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 69, 2506–2513 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Veltman, J. D. et al. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer 10, 464 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Pan, P. Y. et al. Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 111, 219–228 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• DeNardo, D. et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1, 54–67 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z. & Colombo, M. P. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor–bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res. 67, 11438–11446 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Veltman, J. D. et al. Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. Br. J. Cancer 103, 629–641 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fernandez, A. et al. Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant. J. Immunol. 186, 264–274 (2011).
  Article CAS PubMed Google Scholar
• Priceman, S. J. et al. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 115, 1461–1471 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fricke, I. et al. Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clin. Cancer Res. 13, 4840–4848 (2007).
  Article CAS PubMed Google Scholar
• Kusmartsev, S. et al. Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. J. Immunol. 181, 346–353 (2008).
  Article CAS PubMed Google Scholar
• Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R. & Albelda, S. M. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin. Cancer Res. 11, 6713–6721 (2005).
  Article CAS PubMed Google Scholar
• Vincent, J. et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res. 70, 3052–3061 (2010).
  Article CAS PubMed Google Scholar
• Kodumudi, K. N. et al. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin. Cancer Res. 16, 4583–4594 (2010).
  Article CAS PubMed Google Scholar
• Mirza, N. et al. All-_trans_-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 66, 9299–9307 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kusmartsev, S. et al. All-_trans_-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63, 4441–4449 (2003).
  CAS PubMed Google Scholar
• Lathers, D., Clark, J., Achille, N. & Young, M. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunol. Immunother. 53, 422–430 (2004).
  Article CAS PubMed Google Scholar
• Watkins, S. K., Egilmez, N. K., Suttles, J. & Stout, R. D. IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J. Immunol. 178, 1357–1362 (2007).
  Article CAS PubMed Google Scholar
• Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G. & Colombo, M. P. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437–3446 (2005).
  Article CAS PubMed Google Scholar
• Kerkar, S. P. et al. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J. Clin. Invest. 121, 4746–4757 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chmielewski, M., Kopecky, C., Hombach, A. & Abken, H. IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively muster an antigen-independent macrophage response on tumor cells that shut down tumor antigen expression. Cancer Res. 71, 5697–5706 (2011). References 196 and 197 show that it is possible to reprogramme the tumour environment through the adoptive transfer of T cells that recognize a tumour antigen and that are engineered to release IL-12.
  Article CAS PubMed Google Scholar
• Weiss, J. M. et al. Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy. J. Exp. Med. 207, 2455–2467 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Beatty, G. L. et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331, 1612–1616 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rolny, C. et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19, 31–44 (2011).
  Article CAS PubMed Google Scholar
• Hagemann, T. et al. “Re-educating” tumor-associated macrophages by targeting NF-κB. J. Exp. Med. 205, 1261–1268 (2008).
  Article CAS PubMed PubMed Central Google Scholar